Professionnels de santé

Grand public

Presse
Ensemble, améliorons la qualité en santé

Home > Professionnels de santé > Actes - Médicaments - Dispositifs médicaux > Médicaments

Transparency Committee Opinion

STELARA

Date 13 May 2009
Pharmaceutical
formulation

STELARA 45 mg, solution for injection
B/1 x 0.5 ml vial (CIP code: 392 586-2)

ATC code
  1. L04AC05
Active ingredient

ustekinumab
Laboratory / Manufacturer JANSSEN-CILAG
Reason for request Inclusion on the list of medicines reimbursed by National Health Insurance and approved for hospital and various public services use.

Documents

Tools

For more information

Contacts

Contact évaluation des médicaments

transparence@has-sante.fr


 

TAGS

Skin and connective tissue diseases - Drug therapy
Haute Autorité de Santé - 2012